Sanjay Awasthi
Affiliations: | 2016- | Internal Medicine, Division of Heme/Onc | Texas Tech University Health Sciences Center, Lubbock, TX |
Area:
Biochemistry; Glutathione; Ralbp1; TP53; Antioxidants; CacinogenesisGoogle:
"Sanjay Awasthi"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Yogesh C. Awasthi | research assistant | 1978-1985 | UTMB, Galveston | |
| Satish K. Srivastava | research assistant | 1978-1985 | UTMB | |
| John D. Minna | post-doc | 1990-1991 | University of Texas Southwestern Medical Center at Dallas | |
| Eugene P. Frenkel | research scientist | University of Texas Southwestern Medical Center at Dallas | ||
| Patricia A. Gwirtz | research scientist | 2009 | UT Arlington (Physiology Academic Tree) | |
| (M.S.) | ||||
Children
Sign in to add trainee| Ewa Zajac | grad student | 2006 | UT Arlington |
| Kenneth Drake | grad student | 2007 | UT Arlington |
| Dilki C. Wickramarachchi | grad student | 2007 | UT Arlington |
| Lokesh P. Dalasanur Nagaprashantha | grad student | 2011 | University of North Texas Health Science Center at Fort Worth (Cell Biology Tree) |
| Archana Seharawat | grad student | 2007-2013 | University of North Texas Health Science Center at Fort Worth |
| Sharad S. Singhal | post-doc | 1994-2016 | UT Arlington |
Collaborators
Sign in to add collaborator| Sharad S. Singhal | collaborator | 2011- | City of Hope and Beckman Research Institute |
| Yogesh C. Awasthi | collaborator | 1991-1999 | UTMB |
| Satish K. Srivastava | collaborator | 1991-2019 | UTMB, Galveston |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ramisetty SK, Garg P, Mohanty A, et al. (2023) Regression of ovarian cancer xenografts by depleting or inhibiting RLIP. Biochemical Pharmacology. 217: 115847 |
| Garg P, Awasthi S, Horne D, et al. (2023) The innate effects of plant secondary metabolites in preclusion of gynecologic cancers: Inflammatory response and therapeutic action. Biochimica Et Biophysica Acta. Reviews On Cancer. 188929 |
| Garg P, Garg R, Horne D, et al. (2023) Prognostic significance of natural products against multidrug tumor resistance. Cancer Letters. 557: 216079 |
| Singhal SS, Garg R, Horne D, et al. (2022) RLIP: A necessary transporter protein for translating oxidative stress into pro-obesity and pro-carcinogenic signaling. Biochimica Et Biophysica Acta. Reviews On Cancer. 188803 |
| Nagaprashantha LD, Singhal J, Li H, et al. (2022) Correction: 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer. Oncotarget. 13: 331 |
| Bose C, Hindle A, Lee J, et al. (2021) Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells. Cancers. 13 |
| Singh SP, Lee J, Bose C, et al. (2021) Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis. Cancers. 13 |
| Singhal SS, Srivastava S, Mirzapoiazova T, et al. (2021) Targeting the mercapturic acid pathway for the treatment of melanoma. Cancer Letters |
| Singhal SS, Mohanty A, Kulkarni P, et al. (2021) RLIP Depletion Induces Apoptosis Associated with Inhibition of JAK2/STAT3 Signaling in Melanoma Cells. Carcinogenesis |
| Singhal J, Kulkarni P, Horne D, et al. (2021) Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP. Molecular Carcinogenesis |